ADULT CML

Clinical trials for ADULT CML explained in plain language.

Never miss a new study

Get alerted when new ADULT CML trials appear

Sign up with your email to follow new studies for ADULT CML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Two-Pronged attack: new leukemia drug strategy aims for deeper remission

Disease control Recruiting now

This study is testing a new drug, asciminib, for adults newly diagnosed with a slow-growing type of blood cancer called chronic myeloid leukemia (CML). The goal is to see if asciminib alone can drive the cancer into a very deep remission. If it doesn't work well enough after two …

Matched conditions: ADULT CML

Phase: PHASE2 • Sponsor: Augusta University • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

ADULT CML

Get alerted when new ADULT CML trials appear

Two-Pronged attack: new leukemia drug strategy aims for deeper remission